Savvy Updates, 9/21/20: Islet Viability Matrix (UPenn), Tuina Therapy for Insulin Delivery, Antibiotics and T1D Heart Disease, Impact of Covid-19 on Research & Clinical Trials
Penn researchers advance potential cure for type 1 diabetes was reported by Michael Tanenbaum for the PhillyVoice.com, 8 September 2020. A cure for type 1 diabetes appears to be one step closer to reality after researchers at the University of Pennsylvania...
Savvy Updates, 8/10/20: Non-invasive BG Measurement, Pill Therapy for T1D, Exercise and Insulin Dosing
New accurate, non invasive method for blood sugar estimation developed was discussed by Dr. Kamal Kant Kohli for MedicalDialogues.in, 31 July 2020. Researchers have developed a new accurate metabolic heat conformation (MHC) method, for the noninvasive...
Savvy Updates, 7/20/20: Total Cost of Diabetes Supplies, Covid Unusual in T1D, Movano Non-Invasive CGM, People Hate Masks
People with Type 1 Spend More on Supplies Than on Insulin was reported by Sara Seitz for InsulinNation.com, 16 July 2020. While bills to lower diabetes spending focus on insulin price caps, most T1Ds spend more out-of-pocket on diabetes supplies The research from...
Savvy Looping, 7/15/20: Libre2 vs. G6, INSPIRE & Psychosocial Impact of Tech
Comparing the Libre2 and Dexcom G6 as RT-CGM using #WeAreNotWaiting software was written by Tim Street on his website, Diabettech – Diabetes and Technology, 24 February 2020. This is a GREAT, in-depth comparison of the new Abbott Libre2 with the current...
Savvy Updates, 7/13/20: Medtronic + Tandem Cross-Patent Deal, Insulin Sensors
Medtronic inks cross license deal with Tandem Diabetes Care, as reported on 0 July 2020. Medtronic plc and Tandem Diabetes Care today announced that they have entered into a non-exclusive patent cross-license agreement for certain technologies in the field of...
More Diabetes Blogs